There has been nothing in their data to indicate that the product works
when ACAD put out the their original failed data I believe they mentioned that it worked in parkinson's patients but it wasn't a believeble subgroup, but it has shown to work there.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.